BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1947093)

  • 1. Three-dimensional gadolinium-enhanced MR imaging of the breast: pulse sequence with fat suppression and magnetization transfer contrast. Work in progress.
    Pierce WB; Harms SE; Flamig DP; Griffey RH; Evans WP; Hagans JE
    Radiology; 1991 Dec; 181(3):757-63. PubMed ID: 1947093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast-enhanced MR imaging of the breast: comparison of two different doses of gadopentetate dimeglumine.
    Heywang-Köbrunner SH; Haustein J; Pohl C; Beck R; Lommatzsch B; Untch M; Nathrath WB
    Radiology; 1994 Jun; 191(3):639-46. PubMed ID: 8184040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast neoplasms: T2* susceptibility-contrast, first-pass perfusion MR imaging.
    Kuhl CK; Bieling H; Gieseke J; Ebel T; Mielcarek P; Far F; Folkers P; Elevelt A; Schild HH
    Radiology; 1997 Jan; 202(1):87-95. PubMed ID: 8988196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis.
    Buadu LD; Murakami J; Murayama S; Hashiguchi N; Sakai S; Masuda K; Toyoshima S; Kuroki S; Ohno S
    Radiology; 1996 Sep; 200(3):639-49. PubMed ID: 8756909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique.
    Boetes C; Barentsz JO; Mus RD; van der Sluis RF; van Erning LJ; Hendriks JH; Holland R; Ruys SH
    Radiology; 1994 Dec; 193(3):777-81. PubMed ID: 7972823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gadopentetate dimeglumine-enhanced MR imaging of the postoperative lumbar spine: comparison of fat-suppressed and conventional T1-weighted images.
    Mirowitz SA; Shady KL
    AJR Am J Roentgenol; 1992 Aug; 159(2):385-9. PubMed ID: 1632362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [MR mammography of fatty tissue necrosis].
    Kurtz B; Achten C; Audretsch W; Rezai M; Zocholl G
    Rofo; 1996 Oct; 165(4):359-63. PubMed ID: 8963048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined gadolinium-enhanced and fat-saturation MR imaging of renal masses.
    Semelka RC; Hricak H; Stevens SK; Finegold R; Tomei E; Carroll PR
    Radiology; 1991 Mar; 178(3):803-9. PubMed ID: 1994422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contrast medium assisted dynamic MR-mammography after diagnostic and therapeutic interventions on the breast].
    Fischer U; Vosshenrich R; Kopka L; Kahlen O; Grabbe E
    Bildgebung; 1996 Jun; 63(2):94-100. PubMed ID: 8756151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast disease: tissue characterization with Gd-DTPA enhancement profiles.
    Stack JP; Redmond OM; Codd MB; Dervan PA; Ennis JT
    Radiology; 1990 Feb; 174(2):491-4. PubMed ID: 2296657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
    Low RN; Francis IR; Herfkens RJ; Jeffrey RB; Glazer GM; Foo TK; Shimakawa A; Pelc NJ
    AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-enhanced MR angiography for the diagnosis of intracranial vascular disease: optimal dose of gadopentetate dimeglumine.
    Jung HW; Chang KH; Choi DS; Han MH; Han MC
    AJR Am J Roentgenol; 1995 Nov; 165(5):1251-5. PubMed ID: 7572513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cranial tissues: appearance at gadolinium-enhanced and nonenhanced MR imaging with magnetization transfer contrast.
    Elster AD; King JC; Mathews VP; Hamilton CA
    Radiology; 1994 Feb; 190(2):541-6. PubMed ID: 8284413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary experience with gadolinium-enhanced dynamic MR imaging for uterine neoplasms.
    Hirano Y; Kubo K; Hirai Y; Okada S; Yamada K; Sawano S; Yamashita T; Hiramatsu Y
    Radiographics; 1992 Mar; 12(2):243-56. PubMed ID: 1561414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morton neuroma: evaluation with MR imaging performed with contrast enhancement and fat suppression.
    Terk MR; Kwong PK; Suthar M; Horvath BC; Colletti PM
    Radiology; 1993 Oct; 189(1):239-41. PubMed ID: 8372200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observations.
    Kaiser WA; Zeitler E
    Radiology; 1989 Mar; 170(3 Pt 1):681-6. PubMed ID: 2916021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laser therapy for breast cancer: MR imaging and histopathologic correlation.
    Mumtaz H; Hall-Craggs MA; Wotherspoon A; Paley M; Buonaccorsi G; Amin Z; Wilkinson I; Kissin MW; Davidson TI; Taylor I; Bown SG
    Radiology; 1996 Sep; 200(3):651-8. PubMed ID: 8756910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The variability of fibroadenoma in contrast-enhanced dynamic MR mammography.
    Brinck U; Fischer U; Korabiowska M; Jutrowski M; Schauer A; Grabbe E
    AJR Am J Roentgenol; 1997 May; 168(5):1331-4. PubMed ID: 9129437
    [No Abstract]   [Full Text] [Related]  

  • 19. MR imaging of peritoneal disease: comparison of contrast-enhanced fast multiplanar spoiled gradient-recalled and spin-echo imaging.
    Low RN; Sigeti JS
    AJR Am J Roentgenol; 1994 Nov; 163(5):1131-40. PubMed ID: 7976889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spinal cord pial metastases: MR imaging with gadopentetate dimeglumine.
    Lim V; Sobel DF; Zyroff J
    AJR Am J Roentgenol; 1990 Nov; 155(5):1077-84. PubMed ID: 2120938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.